A phase I/II trial of intravenous L-2-oxothiazolidine-4-carboxylic acid (procysteine) in asymptomatic HIV-infected subjects

Twenty-four asymptomatic, HIV-1-seropositive subjects with CD4 cell counts of > or = 400/microliters participated in a Phase I/II, dose escalation trial of intravenous L-2-oxothiazolidine-4-carboxylic acid (OTC: Procysteine). Four groups of six subjects each were consecutively assigned to receive...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of acquired immune deficiency syndromes (1988) 1994-04, Vol.7 (4), p.369-374
Hauptverfasser: KALAYJIAN, R. C, SKOWRON, G, STORY, K. O, ROWE, W. B, THOMPSON, K, GOLDBERG, S, TRIMBO, S, LEDERMAN, M. M, EMGUSHOV, R.-T, CHANCE, M, SPELL, S. A, BORUM, P. R, WEBB, L. S, MAYER, K. H, JACKSON, J. B, YEN-LIEBERMAN, B
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!